Apadaz 8.16 mg / 325 mg Oral Tablet
RxNorm 2118734
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2118734 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: apadaz 8.16 mg / 325 mg Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBDPrescribable
Semantic Branded Drug (SBD):
Acetaminophen 325 mg / benzhydrocodone 8.16 mg Oral Tablet [Apadaz]
(Atom ID: 12359519)
PSNPrescribable
Prescribable Name (PSN):
Apadaz 8.16 mg / 325 mg Oral Tablet
(Atom ID: 12939865)
SYPrescribable
Synonym (SY):
Apadaz 8.16 mg / 325 mg Oral Tablet
(Atom ID: 10825892)
SYPrescribable
Synonym (SY):
APAP 325 mg / benzhydrocodone 8.16 mg Oral Tablet [Apadaz]
(Atom ID: 10826072)
Patient Education
Benzhydrocodone and Acetaminophen
The combination of benzhydrocodone and acetaminophen is used to relieve acute pain (pain that begins suddenly, has a specific cause, and is expected to go away when the cause of the pain is healed) that cannot be relieved by other non-opioid pain medications. Benzhydrocodone is in a class of medications called opiate (narcotic) analgesics. It works by changing the way the brain and nervous system respond to pain. Acetaminophen is in a class of medications called analgesics (pain relievers) and antipyretics (fever reducers). When acetaminophen is used in combination with benzhydrocodone to treat pain, it works by changing the way the body senses pain.
[Learn More]
* Please review the disclaimer below.